NEXPOINT RESIDENTIAL (NXRT) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:NXRT • US65341D1028

30.12 USD
-0.29 (-0.95%)
At close: Feb 9, 2026
30.12 USD
0 (0%)
After Hours: 2/9/2026, 8:21:14 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Taking everything into account, NXRT scores 2 out of 10 in our fundamental rating. NXRT was compared to 20 industry peers in the Residential REITs industry. NXRT has a bad profitability rating. Also its financial health evaluation is rather negative. NXRT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year NXRT has reported negative net income.
  • In the past year NXRT had a positive cash flow from operations.
  • NXRT had positive earnings in 4 of the past 5 years.
  • In the past 5 years NXRT always reported a positive cash flow from operatings.
NXRT Yearly Net Income VS EBIT VS OCF VS FCFNXRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

  • The Return On Assets of NXRT (-2.64%) is worse than 90.00% of its industry peers.
  • With a Return On Equity value of -15.06%, NXRT is not doing good in the industry: 90.00% of the companies in the same industry are doing better.
  • The Return On Invested Capital of NXRT (1.26%) is worse than 70.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for NXRT is in line with the industry average of 2.59%.
Industry RankSector Rank
ROA -2.64%
ROE -15.06%
ROIC 1.26%
ROA(3y)0.58%
ROA(5y)1.05%
ROE(3y)2.48%
ROE(5y)4.62%
ROIC(3y)1.37%
ROIC(5y)1.09%
NXRT Yearly ROA, ROE, ROICNXRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

  • NXRT's Profit Margin has declined in the last couple of years.
  • With a Operating Margin value of 11.35%, NXRT is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
  • In the last couple of years the Operating Margin of NXRT has grown nicely.
  • NXRT has a Gross Margin of 63.29%. This is amongst the best in the industry. NXRT outperforms 90.00% of its industry peers.
  • In the last couple of years the Gross Margin of NXRT has declined.
Industry RankSector Rank
OM 11.35%
PM (TTM) N/A
GM 63.29%
OM growth 3Y12.71%
OM growth 5Y7.38%
PM growth 3Y-65.59%
PM growth 5Y-62.11%
GM growth 3Y-12.32%
GM growth 5Y-7.43%
NXRT Yearly Profit, Operating, Gross MarginsNXRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NXRT is destroying value.
  • The number of shares outstanding for NXRT has been reduced compared to 1 year ago.
  • The number of shares outstanding for NXRT has been increased compared to 5 years ago.
  • Compared to 1 year ago, NXRT has a worse debt to assets ratio.
NXRT Yearly Shares OutstandingNXRT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
NXRT Yearly Total Debt VS Total AssetsNXRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • Based on the Altman-Z score of 0.41, we must say that NXRT is in the distress zone and has some risk of bankruptcy.
  • NXRT has a worse Altman-Z score (0.41) than 60.00% of its industry peers.
  • The Debt to FCF ratio of NXRT is 33.86, which is on the high side as it means it would take NXRT, 33.86 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of NXRT (33.86) is comparable to the rest of the industry.
  • NXRT has a Debt/Equity ratio of 4.55. This is a high value indicating a heavy dependency on external financing.
  • NXRT has a worse Debt to Equity ratio (4.55) than 85.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.55
Debt/FCF 33.86
Altman-Z 0.41
ROIC/WACC0.16
WACC7.75%
NXRT Yearly LT Debt VS Equity VS FCFNXRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

  • NXRT has a Current Ratio of 0.72. This is a bad value and indicates that NXRT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NXRT's Current ratio of 0.72 is fine compared to the rest of the industry. NXRT outperforms 65.00% of its industry peers.
  • NXRT has a Quick Ratio of 0.72. This is a bad value and indicates that NXRT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 0.72, NXRT is doing good in the industry, outperforming 70.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.72
NXRT Yearly Current Assets VS Current LiabilitesNXRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The earnings per share for NXRT have decreased strongly by -209.25% in the last year.
  • The earnings per share for NXRT have been decreasing by -65.41% on average. This is quite bad
  • Looking at the last year, NXRT shows a decrease in Revenue. The Revenue has decreased by -4.46% in the last year.
  • The Revenue has been growing slightly by 7.48% on average over the past years.
EPS 1Y (TTM)-209.25%
EPS 3Y-70.76%
EPS 5Y-65.41%
EPS Q2Q%11.43%
Revenue 1Y (TTM)-4.46%
Revenue growth 3Y5.81%
Revenue growth 5Y7.48%
Sales Q2Q%-1.98%

3.2 Future

  • The Earnings Per Share is expected to decrease by -296.71% on average over the next years. This is quite bad
  • NXRT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.23% yearly.
EPS Next Y-6199.6%
EPS Next 2Y-735.03%
EPS Next 3Y-296.71%
EPS Next 5YN/A
Revenue Next Year-2.94%
Revenue Next 2Y-0.29%
Revenue Next 3Y1.37%
Revenue Next 5Y1.23%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NXRT Yearly Revenue VS EstimatesNXRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
NXRT Yearly EPS VS EstimatesNXRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • NXRT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year NXRT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXRT Price Earnings VS Forward Price EarningsNXRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

  • NXRT's Enterprise Value to EBITDA is on the same level as the industry average.
  • NXRT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. NXRT is cheaper than 95.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.62
EV/EBITDA 17.73
NXRT Per share dataNXRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • A cheap valuation may be justified as NXRT's earnings are expected to decrease with -296.71% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-735.03%
EPS Next 3Y-296.71%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • NXRT has a Yearly Dividend Yield of 7.00%, which is a nice return.
  • NXRT's Dividend Yield is a higher than the industry average which is at 40.66.
  • NXRT's Dividend Yield is rather good when compared to the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 7%

5.2 History

  • On average, the dividend of NXRT grows each year by 10.88%, which is quite nice.
  • NXRT has been paying a dividend for at least 10 years, so it has a reliable track record.
  • NXRT has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)10.88%
Div Incr Years9
Div Non Decr Years9
NXRT Yearly Dividends per shareNXRT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • NXRT has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-109.03%
EPS Next 2Y-735.03%
EPS Next 3Y-296.71%
NXRT Yearly Income VS Free CF VS DividendNXRT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

More info and screens

Find the best dividend stocksShow peers with best dividend

NEXPOINT RESIDENTIAL

NYSE:NXRT (2/9/2026, 8:21:14 PM)

After market: 30.12 0 (0%)

30.12

-0.29 (-0.95%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)10-28
Earnings (Next)02-24
Inst Owners76.86%
Inst Owner Change0.09%
Ins Owners13.26%
Ins Owner Change-1.14%
Market Cap763.84M
Revenue(TTM)252.99M
Net Income(TTM)-48.65M
Analysts72.86
Price Target33.46 (11.09%)
Short Float %3.29%
Short Ratio3.59
Dividend
Industry RankSector Rank
Dividend Yield 7%
Yearly Dividend1.93
Dividend Growth(5Y)10.88%
DP-109.03%
Div Incr Years9
Div Non Decr Years9
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.4%
Min EPS beat(2)12.33%
Max EPS beat(2)18.46%
EPS beat(4)3
Avg EPS beat(4)-34.15%
Min EPS beat(4)-176.12%
Max EPS beat(4)18.46%
EPS beat(8)6
Avg EPS beat(8)63.98%
EPS beat(12)7
Avg EPS beat(12)18.82%
EPS beat(16)9
Avg EPS beat(16)53.78%
Revenue beat(2)0
Avg Revenue beat(2)-1.79%
Min Revenue beat(2)-2%
Max Revenue beat(2)-1.59%
Revenue beat(4)0
Avg Revenue beat(4)-1.66%
Min Revenue beat(4)-2%
Max Revenue beat(4)-1.36%
Revenue beat(8)2
Avg Revenue beat(8)3.27%
Revenue beat(12)3
Avg Revenue beat(12)1.74%
Revenue beat(16)5
Avg Revenue beat(16)1.32%
PT rev (1m)-2.57%
PT rev (3m)-7.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.16%
EPS NY rev (1m)1.48%
EPS NY rev (3m)3.29%
Revenue NQ rev (1m)-0.23%
Revenue NQ rev (3m)-0.54%
Revenue NY rev (1m)-0.22%
Revenue NY rev (3m)-0.44%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.02
P/FCF 17.62
P/OCF 9.1
P/B 2.37
P/tB 2.37
EV/EBITDA 17.73
EPS(TTM)-1.89
EYN/A
EPS(NY)-1.35
Fwd EYN/A
FCF(TTM)1.71
FCFY5.68%
OCF(TTM)3.31
OCFY10.99%
SpS9.98
BVpS12.73
TBVpS12.73
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.64%
ROE -15.06%
ROCE 1.59%
ROIC 1.26%
ROICexc 1.27%
ROICexgc 1.28%
OM 11.35%
PM (TTM) N/A
GM 63.29%
FCFM 17.14%
ROA(3y)0.58%
ROA(5y)1.05%
ROE(3y)2.48%
ROE(5y)4.62%
ROIC(3y)1.37%
ROIC(5y)1.09%
ROICexc(3y)1.38%
ROICexc(5y)1.1%
ROICexgc(3y)1.43%
ROICexgc(5y)1.13%
ROCE(3y)1.73%
ROCE(5y)1.38%
ROICexgc growth 3Y22.72%
ROICexgc growth 5Y15.26%
ROICexc growth 3Y21.87%
ROICexc growth 5Y14.79%
OM growth 3Y12.71%
OM growth 5Y7.38%
PM growth 3Y-65.59%
PM growth 5Y-62.11%
GM growth 3Y-12.32%
GM growth 5Y-7.43%
F-Score4
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 4.55
Debt/FCF 33.86
Debt/EBITDA 11.72
Cap/Depr 42.01%
Cap/Sales 16.04%
Interest Coverage 0.32
Cash Conversion 66.98%
Profit Quality N/A
Current Ratio 0.72
Quick Ratio 0.72
Altman-Z 0.41
F-Score4
WACC7.75%
ROIC/WACC0.16
Cap/Depr(3y)106.97%
Cap/Depr(5y)173.62%
Cap/Sales(3y)38.98%
Cap/Sales(5y)66.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-209.25%
EPS 3Y-70.76%
EPS 5Y-65.41%
EPS Q2Q%11.43%
EPS Next Y-6199.6%
EPS Next 2Y-735.03%
EPS Next 3Y-296.71%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.46%
Revenue growth 3Y5.81%
Revenue growth 5Y7.48%
Sales Q2Q%-1.98%
Revenue Next Year-2.94%
Revenue Next 2Y-0.29%
Revenue Next 3Y1.37%
Revenue Next 5Y1.23%
EBIT growth 1Y-15.85%
EBIT growth 3Y19.26%
EBIT growth 5Y15.4%
EBIT Next Year18718%
EBIT Next 3Y488.73%
EBIT Next 5Y288.05%
FCF growth 1Y206.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.06%
OCF growth 3Y0.14%
OCF growth 5Y7.45%

NEXPOINT RESIDENTIAL / NXRT FAQ

What is the ChartMill fundamental rating of NEXPOINT RESIDENTIAL (NXRT) stock?

ChartMill assigns a fundamental rating of 2 / 10 to NXRT.


Can you provide the valuation status for NEXPOINT RESIDENTIAL?

ChartMill assigns a valuation rating of 2 / 10 to NEXPOINT RESIDENTIAL (NXRT). This can be considered as Overvalued.


What is the profitability of NXRT stock?

NEXPOINT RESIDENTIAL (NXRT) has a profitability rating of 3 / 10.


What is the financial health of NEXPOINT RESIDENTIAL (NXRT) stock?

The financial health rating of NEXPOINT RESIDENTIAL (NXRT) is 2 / 10.


What is the expected EPS growth for NEXPOINT RESIDENTIAL (NXRT) stock?

The Earnings per Share (EPS) of NEXPOINT RESIDENTIAL (NXRT) is expected to decline by -6199.6% in the next year.